All In Biotech

Free tool

FAERS Monitor: Viibryd

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 022567 or its brand name (Viibryd, Vilazodone Hydrochloride). Reports on generic versions are filed under their own applications.

Reports

9,233

Serious

3,618

39% of reports

Hospitalization

1,023

Death reported

188

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • off label use1,096
  • nausea786
  • diarrhoea783
  • anxiety635
  • insomnia620
  • drug ineffective566
  • headache544
  • depression492
  • dizziness485
  • fatigue463
  • suicidal ideation417
  • feeling abnormal402
  • weight increased299
  • paraesthesia296
  • vomiting277

Reports by year received

View as table
YearReports
20091
2011460
20121,132
2013738
2014524
2015444
2016880
2017736
2018562
2019743
2020829
2021562
2022484
2023380
2024296
2025279
2026183

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,044,926 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
suicidal ideationSignal41710.49.53,541
insomniaSignal6205.34.92,189
anxietySignal6355.14.72,108
depressionSignal4924.94.51,553
paraesthesiaSignal2964.33.8748
feeling abnormalSignal4023.83.5845
weight increasedSignal2993.02.7412
off label useSignal1,0962.92.71,373
diarrhoeaSignal7832.82.6907
nauseaSignal7862.32.1574
dizzinessSignal4852.22.0330
headache5442.01.8270
fatigue4631.41.244
vomiting2771.31.224
drug ineffective5661.00.90

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.